Israel Society of Anesthesiologists   Report issue

Academic/Hospital Phase 4
Founded: Jerusalem Israel (1955)

Organization Overview

First Clinical Trial
2020
NCT04251962
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Israel Society of Anesthesiologists

Active Ingredients

Drugs in Phase 4 Trials (2)

bupivacaine (Exparel) (1 trial)

fentanyl (Innovar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2